Use of an innovative system and nanotechnology-based strategy for therapeutic applications of Gla-rich protein (GRP)
Introduction: Gla-rich protein (GRP) is a vitamin K-dependent protein (VKDP) acting as a calcification inhibitor and anti-inflammatory agent in cardiovascular and articular systems, and THP1 monocyte/macrophage cells [1,2]. Calcification and inflammation processes are known to be involved in the eti...
Main Author: | |
---|---|
Other Authors: | , , , , , , , , |
Format: | article |
Language: | eng |
Published: |
2020
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.1/14526 |
Country: | Portugal |
Oai: | oai:sapientia.ualg.pt:10400.1/14526 |